COVID has driven progress across much of the healthcare industry.

We believe this will transform the development and testing of new treatments and technologies after the pandemic.

Such healthcare breakthroughs are ever more important as the world’s population ages.

In the years ahead, the world will depend even more – and spend more – on healthcare than at any time in history.

The healthcare opportunity

We see opportunities among large, quality pharma companies that pay high and growing dividends.

Medical technology, life sciences and tools also offer attractive potential.

For suitable investors, private managers of biotech strategies offer exposure to transformative growth area.